PregLem Company
PregLem is a Swiss-based specialty biopharmaceutical company dedicated to the development and commercialisation of innovative drugs for women’s reproductive medicine.
Industry:
Reproductive Health & Contraception
Headquarters:
Geneva, Geneve, Switzerland
Founded Date:
01-01-2006
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
4
Total Funding:
$58,248,124
Last Funding Date:
2007-12-04
Last Funding Type:
Series B
Register and Claim Ownership